Actinium Pharmaceuticals, Inc. (ATNM)

1.69 +0.10 (+6.29%) USD  |  NYAM  |  Dec 19, 16:00
1.70 +0.01 (+0.59%) After-Hours: 20:00
More

Actinium Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Arcus Biosciences, Inc. Upgrade
Apyx Medical Corp. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade